Tomosynthesis Mammographic Imaging Screening Trial (TMIST)


Tomosynthesis Mammographic Imaging Screening Trial (TMIST)

This is a screening trial. The purpose of this trial is to determine if
tomosynthesis (3-D) mammography detects breast cancer at earlier stage than
current method of 2-D digital mammography.

Are you Eligible? (Inclusion Criteria)

-Patients must be women between 45 and 75 years of age at the time of study
-Women of childbearing potential must not be pregnant or lactating.
-Patients must be scheduled for, or have intent to schedule, a screening
-Patients must not have symptoms or signs of breast disease.
-Patients must not have had a screening mammogram within the last
11 months prior to date of randomization.

Specialty Area(s)

Trial Location

Herbert Irving Comprehensive Cancer Center
161 Fort Washington Ave.
Herbert Irving Pavilion
New York, NY 10032
United States